-
-
-
-
-
-
-
Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
-
-
-
-
-
-
-
Immunic Inc. (IMUX) Misses Q1 EPS by 4c
-
-
-
-
-
-
-
Immunic to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide Corporate Update
-
-
-
-
-
-
-
Immunic Inc. (IMUX) Misses Q4 EPS by 303c
-
-
-
-
-
-
-
Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide Corporate Update
-
-
-
-
-
-
-
Immunic Inc. (IMUX) Reports Q3 EPS of ($0.76), Cash and Cash Equivalents of $110.4M
-
-
-
-
-
-
-
Immunic, Inc. Reports Third Quarter 2020 Financial Results and Provides Corporate Update
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

